Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7AEL

alpha 1-antitrypsin (C232S) complexed with GSK716

This is a non-PDB format compatible entry.
Summary for 7AEL
Entry DOI10.2210/pdb7ael/pdb
DescriptorAlpha-1-antitrypsin, ~{N}-[(1~{S},2~{R})-1-(3-fluoranyl-2-methyl-phenyl)-1-oxidanyl-pentan-2-yl]-2-oxidanylidene-1,3-dihydroindole-4-carboxamide, SULFATE ION, ... (4 entities in total)
Functional Keywordsserpin, serine protease inhibitor, protein binding
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight46062.16
Authors
Chung, C. (deposition date: 2020-09-17, release date: 2021-03-10, Last modification date: 2024-05-01)
Primary citationLomas, D.A.,Irving, J.A.,Arico-Muendel, C.,Belyanskaya, S.,Brewster, A.,Brown, M.,Chung, C.W.,Dave, H.,Denis, A.,Dodic, N.,Dossang, A.,Eddershaw, P.,Klimaszewska, D.,Haq, I.,Holmes, D.S.,Hutchinson, J.P.,Jagger, A.M.,Jakhria, T.,Jigorel, E.,Liddle, J.,Lind, K.,Marciniak, S.J.,Messer, J.,Neu, M.,Olszewski, A.,Ordonez, A.,Ronzoni, R.,Rowedder, J.,Rudiger, M.,Skinner, S.,Smith, K.J.,Terry, R.,Trottet, L.,Uings, I.,Wilson, S.,Zhu, Z.,Pearce, A.C.
Development of a small molecule that corrects misfolding and increases secretion of Z alpha 1 -antitrypsin.
Embo Mol Med, 13:e13167-e13167, 2021
Cited by
PubMed Abstract: Severe α -antitrypsin deficiency results from the Z allele (Glu342Lys) that causes the accumulation of homopolymers of mutant α -antitrypsin within the endoplasmic reticulum of hepatocytes in association with liver disease. We have used a DNA-encoded chemical library to undertake a high-throughput screen to identify small molecules that bind to, and stabilise Z α -antitrypsin. The lead compound blocks Z α -antitrypsin polymerisation in vitro, reduces intracellular polymerisation and increases the secretion of Z α -antitrypsin threefold in an iPSC model of disease. Crystallographic and biophysical analyses demonstrate that GSK716 and related molecules bind to a cryptic binding pocket, negate the local effects of the Z mutation and stabilise the bound state against progression along the polymerisation pathway. Oral dosing of transgenic mice at 100 mg/kg three times a day for 20 days increased the secretion of Z α -antitrypsin into the plasma by sevenfold. There was no observable clearance of hepatic inclusions with respect to controls over the same time period. This study provides proof of principle that "mutation ameliorating" small molecules can block the aberrant polymerisation that underlies Z α -antitrypsin deficiency.
PubMed: 33512066
DOI: 10.15252/emmm.202013167
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.76 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon